Liquid crystalline phase nanodispersions enable skin delivery of siRNA

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 1, 2013, Pages 16-24

  Vicentini, Fabiana Testa Moura De Carvalho ^a   Depieri, Lívia Vieira ^a   Polizello, Ana Cristina Morseli ^a   Ciampo, José Orestes Del ^a   Spadaro, Augusto César Cropanese ^a   Fantini, Márcia C A ^a   Vitória Lopes Badra Bentley, Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Liquid crystalline phase; Nanodispersions; Skin penetration; Small interfering RNA; Topical delivery

Indexed keywords

AMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROL OLEATE; OLEYLAMINE; POLYETHYLENEIMINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; DISPERSION; DRUG DELIVERY SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; LIQUID CRYSTALLINE PHASE NANODISPERSION; MACROMOLECULE; NONHUMAN; PHYSICAL CHEMISTRY; SKIN IRRITATION; SKIN PENETRATION; SWINE; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY;

AMINES; ANIMALS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCERIDES; LIQUID CRYSTALS; MALE; MICE; MICE, HAIRLESS; NANOPARTICLES; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; SKIN; SKIN ABSORPTION; SWINE;

EID: 84871927011     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.08.011     Document Type: Article

References (25)

1. D. De Paula, M.V. Bentley, and R.I. Mahato Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting RNA 13 4 2007 431 456
2. E. Gonzalez-Gonzalez, H. Ra, R.P. Hickerson, Q. Wang, W. Piyawattanametha, M.J. Mandella, G.S. Kino, D. Leake, A.A. Avilion, O. Solgaard, T.C. Doyle, C.H. Contag, and R.L. Kaspar SiRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model Gene Ther. 16 8 2009 963 972
3. A.R. de Fougerolles Delivery vehicles for small interfering RNA in vivo Hum. Gene Ther. 19 2 2008 125 132
4. M. Takanashi, K. Oikawa, K. Sudo, M. Tanaka, K. Fujita, A. Ishikawa, S. Nakae, R.L. Kaspar, M. Matsuzaki, M. Kudo, and M. Kuroda Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse Gene Ther. 16 8 2009 982 989
5. M.A. Tran, R. Gowda, A. Sharma, E.J. Park, J. Adair, M. Kester, N.B. Smith, and G.P. Robertson Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development Cancer Res. 68 18 2008 7638 7649
6. V.D. Thanik, M.R. Greives, O.Z. Lerman, N. Seiser, W. Dec, C.C. Chang, S.M. Warren, J.P. Levine, and P.B. Saadeh Topical matrix-based siRNA silences local gene expression in a murine wound model Gene Ther. 14 17 2007 1305 1308
7. P. Ritprajak, M. Hashiguchi, and M. Azuma Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells Mol. Ther. 16 7 2008 1323 1330
8. S.A. Leachman, R.P. Hickerson, P.R. Hull, F.J. Smith, L.M. Milstone, E.B. Lane, S.J. Bale, D.R. Roop, W.H. McLean, and R.L. Kaspar Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita J. Dermatol. Sci. 51 3 2008 151 157
9. M. Nakamura, J. Jo, Y. Tabata, and O. Ishikawa Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model Am. J. Pathol. 172 3 2008 650 658
10. M. Jakobsen, K. Stenderup, C. Rosada, B. Moldt, S. Kamp, T.N. Dam, T.G. Jensen, and J.G. Mikkelsen Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model Mol. Ther. 17 10 2009 1743 1753
11. K. Kigasawa, K. Kajimoto, S. Hama, A. Saito, K. Kanamura, and K. Kogure Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis like model rat Int. J. Pharm. 383 1 2010 157 160
12. T. Hsu, and S. Mitragotri Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer Proc. Natl. Acad. Sci. USA 108 38 2011 15816 15821
13. S.Y. Wu, and N.A. McMillan Lipidic systems for in vivo siRNA delivery AAPS J. 11 4 2009 639 652
14. K.A. Howard, S.R. Paludan, M.A. Behlke, F. Besenbacher, B. Deleuran, and J. Kjems Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model Mol. Ther. 17 1 2009 162 168
15. F. Pittella, M. Zhang, Y. Lee, H.J. Kim, T. Tockary, K. Osada, T. Ishii, K. Miyata, N. Nishiyama, and K. Kataoka Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity Biomaterials 32 11 2011 3106 3114
16. G. Cevc, and U. Vierl Nanotechnology and the transdermal route: a state of the art review and critical appraisal J. Control Release 141 3 2010 277 299
17. C.A. Fernandez, and K.G. Rice Engineered nanoscaled polyplex gene delivery systems Mol. Pharm. 6 5 2009 1277 1289
18. X.B. Xiong, H. Uludag, and A. Lavasanifar Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery Biomaterials 30 2 2009 242 253
19. A.J. Convertine, D.S. Benoit, C.L. Duvall, A.S. Hoffman, and P.S. Stayton Development of a novel endosomolytic diblock copolymer for siRNA delivery J. Control Release 133 3 2009 221 229
20. D. Libster, A. Aserin, and N. Garti Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications J. Colloid Interface Sci. 356 2 2011 375 386
21. L.B. Lopes, D.A. Ferreira, D. de Paula, M.T. Garcia, J.A. Thomazini, M.C. Fantini, and M.V. Bentley Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A Pharm. Res. 23 6 2006 1332 1342
22. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 5259 1970 680 685
23. L.B. Lopes, J.L. Lopes, D.C. Oliveira, J.A. Thomazini, M.T. Garcia, M.C. Fantini, J.H. Collett, and M.V. Bentley Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery Eur. J. Pharm. Biopharm. 63 2 2006 146 155
24. F.T. Vicentini, T.R. Simi, J.O. Del Ciampo, N.O. Wolga, D.L. Pitol, M.M. Iyomasa, M.V. Bentley, and M.J. Fonseca Quercetin in w/o microemulsion: in vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo Eur. J. Pharm. Biopharm. 69 3 2008 948 957
25. X. Wu, G.J. Price, and R.H. Guy Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin Mol. Pharm. 6 5 2009 1441 1448